📊 Score Breakdown
Offering Ability
90
Cash Runway
95
Float Risk
47
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
69%
💰 Capital Raise
75%
• Critical: only 1.5 months cash remaining
• Active shelf registration ($9M, 107% of market cap)
🔄 Reverse Split
70%
• 50-day avg $0.49 below $1 exchange minimum
• Only 2 months cash — financial pressure
📉 Score Deterioration
55%
• Score rose 57 points recently (worsening)
• Score already CRITICAL (81/100) — events likely imminent
💹 Market Data
Market Cap$8.63M
Shares Outstanding7.85M
Float4.39M
Cash$715.4K
Debt$2.42M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 53.8% shares (2025Q4 vs prior)
12 institutional holders · 196.4K shares
#1
VANGUARD GROUP INC
51.3K shares
#2
GEODE CAPITAL MANAGEMENT, LLC
37.1K shares
#3
SUSQUEHANNA INTERNATIONAL GROUP, LLP
29.0K shares
+ 9 more holders Sign up free to view →
📉 Short Interest
Short Interest88.4K
Days to Cover1.0
% of Float2.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Apr 30, 2025
xbrl
XBRL CONVERTIBLE
Apr 30, 2023
424B3
ATM
Apr 14, 2026
EFFECT
EFFECT
Apr 13, 2026
S-1/A
SHELF
Mar 24, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NCPL
📊 NCPL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NCPL Signal Convergence & Dark Pool Activity — StonkWhisper
📄 NCPL Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.